U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 26 - July 2, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 26 - July 2, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 06/28/2022
Location: Virtual
Subject: Misinformation and Disinformation
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Tara Kirk Sell (Johns Hopkins University);

Event Date: 06/28/2022
Location: Virtual
Subject: FDA Food Programs
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of various food-related stakeholder groups

Event Date: 06/30/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups interested in infant formula issues

Event Date: 06/30/2022
Location: Silver Spring, MD
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Dennis Lin, Kristy Carr (Bubs Australia); Jennifer Bonadio (Bondi Partners);

Event Date: 06/30/2022
Location: Virtual
Subject: Supply Chain Challenges and Food Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Food and Beverage Association

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 06/27/2022
Location: Virtual
Subject: Researching COVID to Enhance Recovery (RCOVER) Executive Committee Meeting
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: RECOVER Executive Committee Members

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 06/27/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members and staff from the Consumer Brands Association

Event Date: 07/01/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; MICHAEL ROGERS; JUDITH MCMEEKIN; SUSAN MAYNE;
Non FDA Participant/Group: Cathy Burns, Jennifer McEntire (International Fresh Produce Association);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 06/28/2022
Location: Virtual
Subject: Market Regulation of Medical Devices Space and Lessons Learned
FDA Participant/Group: RAVI BHARWANI, MELISSA TORRES, TIMOTHY STENZEL
Non FDA Participant/Group: United Kingdom Health Security Agency

Event Date: 06/30/2022
Location: Virtual
Subject: U.S. - European Union Mutual Recognition Agreement, 7th Joint Sectoral Committee Meeting
FDA Participant/Group: STEVEN SOLOMON, THERESA MULLIN, SUSAN LASKA, JADE PHAM
Non FDA Participant/Group: European Commission - DG Health & Food Safety (SANTE) Unit B4 – Medical Products: Quality, Safety and Innovation

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/30/2022
Location: Virtual
Subject: Co-chaired: SARS-CoV-2 Variant Workshop; Speaker: Latest Developments on Adapted Vaccines and Options for Vaccine Updates
FDA Participant/Group: JERRY WEIR;
Non FDA Participant/Group: Members of International Coalition of Medicines Regulatory Authorities

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 07/01/2022
Location: Virtual
Subject: FDA's Nutrition Priorities
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Georges Benjamin (American Public Health Association);

Official Name: Michele Mital, Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top